Intimation of Closure of Trading window with effect from 01.10.2025 till 48 hours after the declaration of un-audited financial results for the 2nd quarter/half year of FY 2025-26 ended on 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunil Healthcare Ltd has informed the stock exchanges that its trading window for dealing in company securities will be closed for all designated persons and their immediate relatives from October 1, 2025, until 48 hours after the declaration of its unaudited financial results for Q2/H1 of FY 2025-26 (quarter ended September 30, 2025). The closure is being done under the company's Insider Trading Code of Conduct, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. This is a routine compliance measure taken ahead of the upcoming quarterly results announcement. The intimation was signed by Satyendu Pattnaik, Company Secretary & Compliance Officer, on September 25, 2025.
This is a standard regulatory filing and does not directly affect shareholders. However, it signals that the company's Q2 FY2025-26 results are expected soon, which investors should watch for. Designated insiders cannot trade in the stock during the closure period, meaning no insider buying or selling will be seen until after results are declared.